Family summary
Current and historical shortage references are available across related Decitabine presentations from multiple manufacturers.
- 2 current shortage context pages.
- 7 historical shortage context pages.
- 9 manufacturers represented.
Decitabine - Drug Shortage Information
Public shortage context is available across 9 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
decitabine 50 mg / 20mL Injection 20 mL - NDC 16729-0224-05Accord Healthcare Inc. | 1 VialDecitabine 50 mg / 26mL Injection 26 mL - NDC 55150-0376-01Eugia US LLC | 1 Vial, Single-Dosedecitabine 50 mg / 20mL Injection 20 mL - NDC 70121-1644-01Amneal Pharmaceuticals LLC | 1 Vial, Single-Usedecitabine 50 mg / 1 Injection 1 Vial, Single-Dose - NDC 00143-9385-01Hikma Pharmaceuticals USA Inc. | 1 Vial, Single-Dosedecitabine 50 mg / 20mL Injection 20 mL - NDC 67457-0316-25Mylan Institutional LLC | 1 Vial
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.